Aptevo Therapeutics Stock Price Prediction
| APVO Stock | USD 0.74 0.03 4.23% |
Oversold Vs Overbought
34
Oversold | Overbought |
Aptevo Therapeutics stock price prediction is an act of determining the future value of Aptevo Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Aptevo Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Aptevo Therapeutics and does not consider all of the tangible or intangible factors available from Aptevo Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Aptevo Therapeutics, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Aptevo Therapeutics' stock price prediction:EPS Estimate Next Quarter (0.36) | EPS Estimate Current Year (20.17) | EPS Estimate Next Year (8.07) | Wall Street Target Price 15.25 | EPS Estimate Current Quarter (0.41) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Aptevo Therapeutics based on different types of headlines from major news networks to social media. The Aptevo stock price prediction module provides an analysis of price elasticity to changes in media outlook on Aptevo Therapeutics over a specific investment horizon. Using Aptevo Therapeutics hype-based prediction, you can estimate the value of Aptevo Therapeutics from the perspective of Aptevo Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Aptevo Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Aptevo Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Aptevo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Aptevo Therapeutics after-hype prediction price | USD 0.54 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Aptevo |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aptevo Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Aptevo Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Aptevo Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Aptevo Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Aptevo Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Aptevo Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Aptevo Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Aptevo Therapeutics' historical news coverage. Aptevo Therapeutics' after-hype downside and upside margins for the prediction period are 0.03 and 11.48, respectively. We have considered Aptevo Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Aptevo Therapeutics is extremely dangerous at this time. Analysis and calculation of next after-hype price of Aptevo Therapeutics is based on 3 months time horizon.
Aptevo Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Aptevo Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aptevo Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Aptevo Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.65 | 10.94 | 0.53 | 1.28 | 9 Events / Month | 12 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.74 | 0.54 | 27.40 |
|
Aptevo Therapeutics Hype Timeline
Aptevo Therapeutics is presently traded for 0.74. The entity has historical hype elasticity of -0.53, and average elasticity to hype of competition of 1.28. Aptevo is anticipated to decline in value after the next headline, with the price expected to drop to 0.54. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -27.4%, whereas the daily expected return is presently at -2.65%. The volatility of related hype on Aptevo Therapeutics is about 2268.66%, with the expected price after the next announcement by competition of 2.02. The company has price-to-book (P/B) ratio of 0.05. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aptevo Therapeutics recorded a loss per share of 67.07. The entity last dividend was issued on the 27th of March 2020. The firm had 1:44 split on the 6th of March 2024. Given the investment horizon of 90 days the next anticipated press release will be in about 9 days. Check out Aptevo Therapeutics Basic Forecasting Models to cross-verify your projections.Aptevo Therapeutics Related Hype Analysis
Having access to credible news sources related to Aptevo Therapeutics' direct competition is more important than ever and may enhance your ability to predict Aptevo Therapeutics' future price movements. Getting to know how Aptevo Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Aptevo Therapeutics may potentially react to the hype associated with one of its peers.
Aptevo Therapeutics Additional Predictive Modules
Most predictive techniques to examine Aptevo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aptevo using various technical indicators. When you analyze Aptevo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Aptevo Therapeutics Predictive Indicators
The successful prediction of Aptevo Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Aptevo Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Aptevo Therapeutics based on analysis of Aptevo Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Aptevo Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Aptevo Therapeutics's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.28 | 3.38E-4 | 3.04E-4 | 2.89E-4 | Price To Sales Ratio | 3.0 | 3.8 | 4.37 | 4.15 |
Story Coverage note for Aptevo Therapeutics
The number of cover stories for Aptevo Therapeutics depends on current market conditions and Aptevo Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Aptevo Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Aptevo Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Aptevo Therapeutics Short Properties
Aptevo Therapeutics' future price predictability will typically decrease when Aptevo Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Aptevo Therapeutics often depends not only on the future outlook of the potential Aptevo Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aptevo Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 278.1 K | |
| Cash And Short Term Investments | 16.9 M |
Check out Aptevo Therapeutics Basic Forecasting Models to cross-verify your projections. To learn how to invest in Aptevo Stock, please use our How to Invest in Aptevo Therapeutics guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Aptevo Stock analysis
When running Aptevo Therapeutics' price analysis, check to measure Aptevo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aptevo Therapeutics is operating at the current time. Most of Aptevo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aptevo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aptevo Therapeutics' price. Additionally, you may evaluate how the addition of Aptevo Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Is Aptevo Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptevo Therapeutics. If investors know Aptevo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptevo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (67.07) | Quarterly Revenue Growth (1.00) | Return On Assets (0.61) | Return On Equity (1.24) |
The market value of Aptevo Therapeutics is measured differently than its book value, which is the value of Aptevo that is recorded on the company's balance sheet. Investors also form their own opinion of Aptevo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Aptevo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptevo Therapeutics' market value can be influenced by many factors that don't directly affect Aptevo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptevo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptevo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptevo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.